Industry

In Other News

• Prometheus Enters Oncology Market via Agreement With Rosetta Genomics

• Multiplex Mass Spectrometric Immunoassays Will Improve Cancer Diagnosis

• Beckman Coulter Augments Genomic Services with Cogenics Acquisition

• Independent Market Research Ranks Sysmex in Hematology Instruments

• Noninvasive Prenatal Genetic Screening Tests Are Safer

• Lab21 Expands Microbiology Offering With Acquisition of Biotec

• Nanogen Expands Partnership with HandyLab for IVD Testing

• Innovative Biosensors Develops Rapid Diagnostics System With Progentech

• Millipore Acquires Technology for Developing Antibodies

• Novel Technologies Drive European IVD Cancer Sector

• Beckman To Buy Diagnostics Business from Olympus for $800 Million

• Prediabetes Screening Test Completed Within One Hour

• IVD Sector Not Affected by Current Economic Conditions

• Noninvasive Prenatal Blood Test To Predict Genetic Disorders

• Sequenom Acquires SensiGen and Expands Molecular Diagnostics Portfolio

• XDx Develops Blood Tests To Identify Lupus Biomarkers

• Abbott To Offer New Approach to Pathogen Detection

• Molecular Diagnostics Emerging Rapidly for Routine Patient Care

• EGFR Companion Diagnostics Marketed in United States and Canada

• Competitive Intelligence Can Help Healthcare Companies in Uncertain Times

• Pulmonary Biomarker Surfactant Protein-B Is Used for Diagnosis

• DxS and Amgen Collaborate on Companion Diagnostic for Vectibix

• Laboratories Consolidate Clinical Chemistry and Immunoassay Analyzers